Nurix Therapeutics, Inc. (NRIX) › Weighted Average Diluted SharesNurix Therapeutics, Inc. (NRIX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-11-30: 42.90M2022-11-30: 48.61M2023-11-30: 54.34M2024-11-30: 67.12M2025-11-30: 86.67M86.67M2021-11-30Weighted Average Diluted Shares (shares)2025-11-30Period endedWeighted Average Diluted SharesChange YoYSource filing2025-11-3086.67M+29.1%2026-01-28From 2024-12-012024-11-3067.12M+23.5%2026-01-28From 2023-12-012023-11-3054.34M+11.8%2026-01-28From 2022-12-012022-11-3048.61M+13.3%2025-01-28From 2021-12-012021-11-3042.90M—2023-02-09From 2020-12-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)